in

VCP/p97 as a therapeutic target in KRAS-mutant pancreatic cancer

Genes & Cancer | VCP/p97 as a therapeutic target in KRAS-mutant pancreatic cancer

VCP is an essential gene for KRAS-mutant PDAC. Credit: 2023 Lee et al.

A new research paper, titled “VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer,” was published in Genes & Cancer on March 10, 2023.


Posted by Editor

Announcing Next and The Claw Models

Announcing Next and The Claw Models

Sam Altman didn't take any equity in OpenAI, report says

Sam Altman didn’t take any equity in OpenAI, report says